This study compared mirtazapine with megestrol in the management of cancer-related anorexia–cachexia syndrome in patients with advanced cancer. A randomized, double-blind, controlled clinical trial involving patients with advanced cancer and anorexia–cachexia syndrome was performed. Participants received mirtazapine 30 mg/day or megestrol 320 mg/day for eight weeks. The primary endpoint was the effect of mirtazapine on weight gain and the secondary endpoints were its effect on appetite, muscle strength, physical performance, body composition, adverse events, and medication adherence. Linear regression model with mixed effects was applied and a significance level of 5% was adopted. Fifty-two patients were randomized. Mean age was 65.8 ± 8.4 years. There was weight gain in 52% of the participants in the megestrol group and in 38% in the mirtazapine group after four weeks (p = 0.040). Appetite improved in 92% of the participants in the megestrol group and in 56% in the mirtazapine group after eight weeks (p = 0.007). In the sub-analysis by sex, women showed improvement in appetite (p < 0.001) and weight gain (p < 0.005) in the mirtazapine group, which was not observed in men. Mirtazapine appears to be inferior to megestrol in weight and appetite improvement. However, there may be a difference in the therapeutic response between sexes.
1 January 2024 in Revista da Associação Médica Brasileira
According to the World Health Organization (WHO), cancer is defined as a large group of malignant diseases that have the common characteristic of disordered and abnormal cell growth, which can invade adjacent structures or spread through metastases. According to WHO data, in 2018, 17 million new cases and 9.6 million deaths from cancer were recorded worldwide, generating a great impact not only physically but also emotionally and financially on individuals, families, communities, and health systems1 1 World Health Organization (WHO). Cancer. What is cancer? Geneva: WHO; 2023. [cited on 2023 Oct 15]. Available from: https://www.who.int/health-topics/cancer#tab=tab_1 https://www.who.int/health-topics/cancer... . In Brazil, 704,000 new cases of cancer are expected for each year of the 2023–2025 triennium, with emphasis on the South and Southeast regions, which account for around 70% of cases. Among the most common malignant neoplasms in Brazil, non-melanoma skin neoplasms are the most common (31.3% of total cases), followed by breast neoplasms (10.5%), prostate (10.2%), colon and rectum (6.5%), lung (4.6%), and stomach (3.1%)1 1 World Health Organization (WHO). Cancer. What is cancer? Geneva: WHO; 2023. [cited on 2023 Oct 15]. Available from: https://www.who.int/health-topics/cancer#tab=tab_1 https://www.who.int/health-topics/cancer... ,2 2 Instituto Nacional de Câncer (Brasil). Estimativa 2023: incidência de câncer no Brasil / Instituto Nacional de Câncer. Rio de Janeiro (RJ): INCA; 2022. .
1 January 2024 in Geriatrics Gerontology and Aging
Introduction: The World Health Organization (WHO) has proposed to monitor intrinsic capacity (IC) in the older population as a public health strategy through the Integrated Care for Older People (ICOPE) program. Although the program has been developed based on solid concepts, scientific evidence on its practical applicability is still scarce. Objectives: To evaluate IC in Brazilian older adults, its progress over time, and its association with sociodemographic and health factors and outcomes. To evaluate the psychometric properties of the WHO/ICOPE screening tool. Methods: This is a prospective multicenter cohort study with a 36-month follow-up. We will recruit 3838 people aged ≥60 years, registered in the health care units included in the study by the participating centers. We will collect sociodemographic and health data and will administer tools to assess IC domains, both those provided for in the ICOPE screening tool and the sequence of confirmatory assessments provided for in the program. Participants will be reassessed every 6 months for 36 months. Expected results: To establish the profile of IC in the study population and to understand its progress and the variables associated with the clinical outcomes of interest. To reveal the diagnostic and psychometric properties of the WHO/ICOPE screening tool. The project is funded by the Brazilian National Council for Scientific and Technological Development (CNPq). Relevance: Understanding the potential use of the ICOPE public health strategy proposed by the WHO within the scope of the Brazilian Unified Health System (SUS) by integrating several research centers in the field of Geriatrics and Gerontology throughout Brazil.
1 January 2024 in Geriatrics Gerontology and Aging
Introdução: A Organização Mundial da Saúde (OMS) propõe o monitoramento da capacidade intrínseca (CI) da população idosa como estratégia de saúde pública por meio do Programa ICOPE (Integrated Care for Older People). Embora construído com base em conceitos sólidos, a evidência científica sobre a aplicabilidade prática da proposta ainda é escassa. Objetivo: Avaliar a capacidade intrínseca da população idosa brasileira, sua trajetória e sua associação com variáveis sociodemográficas, de saúde e desfechos. Avaliar as propriedades psicométricas da ferramenta de triagem da estratégia ICOPE da OMS. Metodologia: Coorte multicêntrica prospectiva com seguimento de 36 meses. Serão recrutadas 3.838 pessoas com 60 anos ou mais, cadastradas nas unidades de saúde incluídas no estudo pelos centros participantes. Serão coletados dados sociodemográficos e de saúde e aplicados instrumentos para avaliação dos domínios da CI, tanto aqueles previstos no instrumento de triagem do ICOPE quanto a sequência de avaliações confirmatórias previstas no programa. Os participantes serão acompanhados semestralmente ao longo de 36 meses. Resultados esperados: Estabelecer o perfil da CI na população estudada, entender a sua trajetória e as variáveis associadas aos desfechos clínicos avaliados. Revelar as propriedades diagnósticas e o perfil psicométrico da ferramenta de triagem do ICOPE da OMS. O projeto tem financiamento do Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Relevância: Compreensão sobre o potencial de utilização da estratégia ICOPE de saúde pública proposta pela OMS no âmbito do Sistema Único de Saúde (SUS) pela integração de diversos centros de pesquisa científica na área de Geriatria e Gerontologia de todo o Brasil.
RESUMO Parte significativa da força de trabalho nos hospitais é composta pela equipe de enfermagem, cujos parâmetros de dimensionamento estão definidos. Seu descumprimento compromete a qualidade e a segurança do atendimento, sobrecarrega a equipe e pode provocar descontinuidade de serviços, inclusive o fechamento de leitos. Este estudo avaliou a estratégia ‘Hospital Semana’, no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, como alternativa à desassistência gerada pelo déficit de 20% de profissionais da equipe assistencial, acumulado entre 2016-2019. Trata-se de estudo de caso único, com abordagem de análise de implantação, que integrou dados secundários de leitos e internações, análise documental e entrevistas semiestruturadas com gestores e profissionais-chave do hospital. A estratégia consistiu na gestão flutuante de leitos entre dias úteis e finais de semana (FDS), com bloqueio temporário de até 23% dos leitos elegíveis no FDS. Os resultados demonstraram que, apesar da redução de pessoal, a instituição manteve o número de leitos ativos, a produção de internações e as cirurgias, sem impacto no perfil assistencial e tempo médio de permanência. A experiência, inédita no Sistema Único de Saúde, demonstrou viabilidade e potencial de replicação, especialmente em contextos de escassez de recursos humanos nos hospitais.